Skip to content

Analgesic Efficacy of Ropivacaine Combined with Dexamethasone or Dexmedetomidine for Lower Extremity Nerve Block in Patients Undergoing Knee Arthroplasty: A Randomized Controlled Study

Analgesic Efficacy of Ropivacaine Combined with Dexamethasone or Dexmedetomidine for Lower Extremity Nerve Block in Patients Undergoing Knee Arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118076
Enrollment
Unknown
Registered
2026-02-02
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

0.25% ropivacaine group (group C):Ultrasound-guided combined femoral nerve-obturator nerve-sciatic nerve block using a total volume of 40 ml of 0.25% ropivacaine
10mg dexamethasone + 0.25% ropivacaine group (group Ds1):Ultrasound-guided combined femoral nerve-obturator nerve-sciatic nerve block using a total volume of 40 ml of 10 mg dexamethasone plus 0.25% ro
20mg dexamethasone + 0.25% ropivacaine group (group Ds2):Under ultrasound guidance, a combined femoral nerve-obturator nerve-sciatic nerve block was performed using a total volume of 40 ml of 20 mg de
20ug dexmedetomidine + 0.25% ropivacaine group (group Dm):Under ultrasound guidance, a combined femoral nerve-obturator nerve-sciatic nerve block was performed using a total volume of 40 ml of 20 µg d
20mg dexamethasone + 20ug dexmedetomidine + 0.25% ropivacaine group (group Ds + Dm):Under ultrasound guidance, a combined femoral nerve-obturator nerve-sciatic nerve block was performed using a total

Sponsors

The First People's Hospital of Yunnan Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients scheduled for total knee replacement under general anesthesia, aged 45-70 years, with ASA classification II-III and body mass index (BMI) between 18-28 kg/m2.

Exclusion criteria

Exclusion criteria: Patients with lower limb motor and sensory dysfunction, history of local anesthetic allergy, severe hepatic or renal dysfunction, lower limb vascular diseases, peripheral nervous system disorders, history of diabetes, infection at the puncture site, long-term opioid use, or mental abnormalities that prevent cooperation.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS);

Secondary

MeasureTime frame
Usage of Patient-Controlled Analgesia Pump;Onset time of nerve block;Duration of nerve block;Intraoperative vital signs;Intraoperative drug usage;

Countries

China

Contacts

Public ContactJin Hua

The First People's Hospital of Yunnan Province

jinhuakm@163.com+86 138 8866 8869

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026